Dianthus Therapeutics | MGTA - Capitalisation Boursière

Prix De L'Action
77.76
Variation Quotidienne
-2.24 -2.80%
Mensuellement
47.61%
Annuel
298.97%
Q1 Prévisions
75.43




Capitalisation Boursière Changement Date
Akebia Therapeutics USD 312M 115M 2026-03
Alaunos Therapeutics USD 53M 48M 2026-03
Avita Medical AUD 164.6M 59.13M 2026-03
Celltrion KRW 45.1T 3.3T 2026-03
Cspc Pharmaceutical CNY 106.96B 74.01M 2026-03
Deva Holding AS TRY 17.54B 7.76B 2023-09
Dianthus Therapeutics USD 2.32B 535M 2026-03
Divis Laboratories Ltd INR 1.7T 186.62B 2025-12
IQVIA Holdings USD 38.39B 6.1B 2025-12
Kangmei Pharma CNY 25.93B 2.01B 2026-03
Knight Therapeutics CAD 625.23M 24.71M 2026-03
Laboratorios Farma EUR 4.17B 917.16M 2026-03
Malin Corporation EUR 142.92M 19.65M 2026-02
Medical Developments International AUD 33.66M 28.87M 2026-03
Neuren Pharmaceuticals AUD 1.51B 851.62M 2026-03
Organigram Holdings CAD 174.77M 137.39M 2026-03
Organon & Co USD 1.86B 916.43M 2025-12
Ovoca Bio EUR 7.54M 4.28M 2022-06
Pharma Mar EUR 1.53B 184.71M 2026-03
Qiagen NV USD 7.87B 2.03B 2026-03
Revvity USD 10.97B 1.21B 2025-12
Sartorius EUR 16.41B 2.95B 2025-12
Sino Biopharmaceutical CNY 113.87B 23.82B 2026-03
Tectonic Therapeutic USD 474M 84M 2026-03
Tilray USD 6.95B 6.01B 2026-03
Viatris USD 14.34B 2.8B 2025-12
Xeris Pharmaceuticals USD 788M 515M 2026-03
Zealand Pharma A/S 33.35B 0 2026-03
Zz Pientze Pharmaceu CNY 95.51B 23.22B 2026-03